Bosh sahifaOCEA • OTCMKTS
add
Ocean Biomedical Inc
Yopilish kursi
0,012 $
Kunlik diapazon
0,010 $ - 0,015 $
Yillik diapazon
0,010 $ - 2,09 $
Bozor kapitalizatsiyasi
2,23 mln USD
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
Barron's
1 kun oldin
Berkshire Stock Could Drop 99% and Still Top S&P 500 Over Buffett’s 60-Year Reign
1,81%
1,47%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 1,75 mln | 365,61% |
Sof foyda | 283,00 ming | 101,68% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | — | — |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | — | — |
Jami aktivlari | 902,00 ming | -83,60% |
Jami passivlari | 98,52 mln | 2,34% |
Umumiy kapital | -97,62 mln | — |
Tarqatilgan aksiyalar | 166,01 mln | — |
Narxi/balansdagi bahosi | -0,00 | — |
Aktivlardan daromad | -430,92% | — |
Kapitaldan daromad | 5,65% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 283,00 ming | 101,68% |
Operatsiyalardan naqd pul | -2,52 mln | -190,99% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 2,50 mln | 198,45% |
Naqd pulning sof oʻzgarishi | -16,00 ming | 40,74% |
Boʻsh pul | -4,49 mln | -247,31% |
Haqida
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Tashkil etilgan
2019
Xodimlar soni
7
